The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

In a report released yesterday, Eric Hagen from BTIG maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

BTIG analyst Janine Stichter raised the firm’s price target on Warby Parker (WRBY) to $30 from $22 and keeps a Buy rating on the shares ahead ...

Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule. Event: BTIG’s MedTech, Digital Health, Life Science & Diagnostic Tools Conference 2025 ...

On Thursday, BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib ...

To schedule a one-on-one meeting, investors are encouraged to contact their BTIG representative. This press release includes forward-looking statements that involve risk and uncertainties.